List of bibliographic references
Number of relevant bibliographic references: 46.
[0-20] [
0 - 20][
0 - 46][
20-40]
Ident. | Authors (with country if any) | Title |
---|
000306 (2012) |
Terence K. Y. Lai [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada] | Cell membrane lytic action of metoclopramide and its relation to tardive dyskinesia |
000418 (2011) |
L. Macgillivray [Canada] ; K. B. Reynolds [Canada] ; M. Sickand [Canada] ; P. I. Rosebush [Canada] ; M. F. Mazurek [Canada] | Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra |
000474 (2011) |
Sheng Chen [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada] | Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia |
000628 (2010) |
André R. Troiano [Canada] ; Michael Schulzer [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Vesna Sossi [Canada] ; Siobhan Mccormick [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function |
000769 (2009) |
Stéphane Potvin [Canada] ; Sylvain Grignon [Canada] ; Serge Marchand [Canada] | Human evidence of a supra‐spinal modulating role of dopamine on pain perception |
000778 (2009) |
Philip Seeman [Canada] ; Hong-Chang Guan [Canada] | Glutamate agonists for treating schizophrenia have affinity for dopamine D2High and D3 receptors |
000779 (2009) |
Philip Seeman [Canada] ; Hong-Chang Guan [Canada] | Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2High receptor |
000795 (2009) |
Philip Seeman [Canada] | Dopamine D2High receptors measured ex vivo are elevated in amphetamine‐sensitized animals |
000872 (2008) |
Annie Larouche [Canada] ; Patrick Berube [Canada] ; Philippe Sarret [Canada] ; Sylvain Grignon [Canada] | Subacute H2O2, but not poly(IC), upregulates dopamine D2 receptors in retinoic acid differentiated SH‐SY5Y neuroblastoma |
000884 (2008) |
Joohyung Lee [Canada, Australie] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi Visanji [Canada] ; Jonathan M. Brotchie [Canada] | Receptor‐activity modifying protein 1 expression is increased in the striatum following repeated L‐DOPA administration in a 6‐hydroxydopamine lesioned rat model of Parkinson's disease |
000899 (2008) |
Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Fréderic Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Mehdi Dridi [Canada] ; Nancy Belanger [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys |
000908 (2008) |
Philip Seeman [Canada] ; Carla Caruso [Argentine] ; Mercedes Lasaga [Argentine] | Memantine agonist action at dopamine D2High receptors |
000925 (2008) |
Yuhua Jiang [Canada, République populaire de Chine] ; Lin Pei [Canada] ; Shupeng Li [Canada] ; Min Wang [Canada] ; Fang Liu [Canada] | Extracellular dopamine induces the oxidative toxicity of SH‐SY5Y cells |
000936 (2008) |
Philip Seeman [Canada] | Dopamine D2High receptors on intact cells |
000937 (2008) |
Philip Seeman [Canada] | Dopamine D2High receptors moderately elevated by sertindole |
000938 (2008) |
Philip Seeman [Canada] | Dopamine D2High receptors moderately elevated by bifeprunox and aripiprazole |
000A56 (2007) |
Philip Seeman [Canada] ; Patrick N. Mccormick [Canada] ; Shitij Kapur [Canada] | Increased dopamine D2High receptors in amphetamine‐sensitized rats, measured by the agonist [3H](+)PHNO |
000A92 (2007) |
Philip Seeman [Canada] | Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2High receptors |
000B47 (2006) |
Philip Seeman [Canada] ; Johannes Schwarz [Allemagne] ; Jiang-Fan Chen [États-Unis] ; Henry Szechtman [Canada] ; Melissa Perreault [Canada] ; G. Stanley Mcknight [États-Unis] ; John C. Roder [Canada] ; Rémi Quirion [Canada] ; Patricia Boksa [Canada] ; Lalit K. Srivastava [Canada] ; Kazuhiko Yanai [Japon] ; David Weinshenker [États-Unis] ; Tomiki Sumiyoshi [Japon] | Psychosis pathways converge via D2High dopamine receptors |
000B49 (2006) |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: Effect on adenosine A2A receptors |
000C71 (2005) |
Claudia L. R. Gonzalez [Canada] ; Omar A. Gharbawie [Canada] ; Ian Q. Whishaw [Canada] ; Bryan Kolb [Canada] | Nicotine stimulates dendritic arborization in motor cortex and improves concurrent motor skill but impairs subsequent motor learning |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/ISSN.i -k "Synapse"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/ISSN.i \
-Sk "Synapse" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Checkpoint
|type= indexItem
|index= ISSN.i
|clé= Synapse
}}
| This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 | |